Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine effects in male patients with obstructive sleep apnea
ACTRN12613000858796Phase 3Completed
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of morphine in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Woolcock Institute of Medical Research. Primary endpoint: Sleep time with oxygen saturation below 90% (T90). Started Aug 2013; status: completed.
02
Drugs
morphine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12613000858796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000858796.